ARCHIVES

In Brief: FDA’s Tabor To Head Biological Carcinogenesis in DCE; Steve Larson to Leave NIH for Memorial

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

In Brief: Upton Says Delaney Clause Is Needed: CPSC Drops Effort To Set Policy On Carcinogens

May 4, 1979

Gigliotti Appointed Chief of Education Branch In DRCCA

January 21, 1983

Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis

December 27, 2002

Study: Blood Test More Accurate Than Traditional Tumor Biopsy

April 26, 2013

In Brief; “Sense of Urgency” In Research Is Theme of New AACR President Daniel Von Hoff

April 16, 1999

Susan Blumenthal Said To Be Candidate For Surgeon General

June 12, 2009